Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Quanterix price target raised to $85 from $75 at SVB Leerink » 08:51
03/03/21
03/03
08:51
03/03/21
08:51
QTRX

Quanterix

$77.06 /

-5.61 (-6.79%)

SVB Leerink analyst…

SVB Leerink analyst Puneet Souda raised the firm's price target on Quanterix to $85 from $75 and keeps an Outperform rating on the shares following quarterly results. The analyst argues the company is delivering a conservative 30%-40% revenue CAGR profile over the next three years and deriving nearly 60% of its revenues from biopharma customers that are willing to pay a premium for Quanterix's improved sensitivity.

ShowHide Related Items >><<
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

03/03/21 Canaccord
Quanterix price target raised to $90 from $86 at Canaccord
01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

  • 04
    Feb
  • 07
    Aug
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

Recommendations
Quanterix price target raised to $90 from $86 at Canaccord » 07:12
03/03/21
03/03
07:12
03/03/21
07:12
QTRX

Quanterix

$77.06 /

-5.61 (-6.79%)

Canaccord analyst Max…

Canaccord analyst Max Mascucci raised the firm's price target on Quanterix to $90 from $86 and keeps a Buy rating on the shares. The analyst noted the company delivered Q4 results that matched its preannouncement and provided updates that support its multi-year runway in both research and clinical markets.

ShowHide Related Items >><<
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

  • 04
    Feb
  • 07
    Aug
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

On The Fly
Fly Intel: After-Hours Movers » 19:16
03/02/21
03/02
19:16
03/02/21
19:16
MRVI

Maravai Lifesciences

$35.01 /

-1.43 (-3.92%)

, AMBA

Ambarella

$113.78 /

-4.91 (-4.14%)

, QTRX

Quanterix

$77.06 /

-5.61 (-6.79%)

, LYFT

Lyft

$57.06 /

-0.26 (-0.45%)

, FUBO

FuboTV

$41.96 /

+3.24 (+8.37%)

, BGS

B&G Foods

$30.44 /

-0.36 (-1.17%)

, GO

Grocery Outlet

$36.12 /

+0.19 (+0.53%)

, VEC

Vectrus

$55.59 /

+0.89 (+1.63%)

, ROST

Ross Stores

$117.75 /

-2.63 (-2.18%)

, NVEE

NV5 Global

$102.47 /

-2.59 (-2.47%)

, REAL

RealReal

$26.70 /

-1.48 (-5.25%)

, RVMD

Revolution Medicines

$44.36 /

-1.57 (-3.42%)

, JWN

Nordstrom

$37.45 /

-0.5 (-1.32%)

, URBN

Urban Outfitters

$33.75 /

-0.4 (-1.17%)

, ARNA

Arena Pharmaceuticals

$76.67 /

-3.44 (-4.29%)

, SSYS

Stratasys

$32.27 /

-4.12 (-11.32%)

, ICAD

iCAD

$18.88 /

-0.3 (-1.56%)

, ABNB

Airbnb

$189.68 /

-6.16 (-3.15%)

Check out this evening's…

ShowHide Related Items >><<
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ICAD iCAD
$18.88 /

-0.3 (-1.56%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
12/16/20 KeyBanc
Maravai Lifesciences initiated with an Overweight at KeyBanc
12/15/20 Morgan Stanley
Maravai Lifesciences initiated with an Overweight at Morgan Stanley
12/15/20 Baird
Baird starts Maravai Lifesciences at Outperform with $31 price target
AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

02/24/21 Deutsche Bank
Ambarella price target raised to $100 from $75 at Deutsche Bank
01/21/21 Stifel
Ambarella price target raised to $118 from $110 at Stifel
01/13/21 Roth Capital
Ambarella upgraded to Buy with $130 price target at Roth Capital
01/13/21 Roth Capital
Ambarella upgraded to Buy from Neutral at Roth Capital
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
LYFT Lyft
$57.06 /

-0.26 (-0.45%)

02/11/21 KeyBanc
Uber price target raised to $75 from $63 at KeyBanc
02/11/21 Needham
Needham transfers coverage on Lyft, raises price target $70 from $50
02/10/21 DA Davidson
Lyft price target raised to $66 from $58 at DA Davidson
02/10/21 Jefferies
Lyft price target raised to $75 from $70 at Jefferies
FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

02/01/21 Wedbush
FuboTV price target raised to $50 from $40 at Wedbush
01/21/21 Barrington
FuboTV initiated with an Outperform at Barrington
01/19/21 LightShed Partners
FuboTV price target lowered to $6.50 from $8 at LightShed Partners
01/12/21 Roth Capital
FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital
BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

01/19/21 Stephens
B&G Foods initiated with an Equal Weight at Stephens
01/05/21 Credit Suisse
B&G Foods downgraded to Underperform from Neutral at Credit Suisse
07/28/20 Seaport Global
B&G Foods initiated with a Neutral at Seaport Global
06/12/20
Fly Intel: Top five analyst initiations
GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

11/18/20 Berenberg
Grocery Outlet initiated with a Buy at Berenberg
11/11/20 DA Davidson
Grocery Outlet price target lowered to $50 from $53 at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
08/14/20 DA Davidson
Grocery Outlet initiated with a Buy at DA Davidson
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

05/19/20 B. Riley
B. Riley FBR sees path for Vectrus shares to top $70
03/05/20 B. Riley
Vectrus price target raised to $60 from $55 at B. Riley FBR
03/04/20 Noble Capital
Vectrus upgraded to Outperform from Market Perform at Noble Capital
ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

01/21/21 Deutsche Bank
Ross Stores price target raised to $129 from $123 at Deutsche Bank
01/04/21 JPMorgan
Ross Stores price target raised to $128 from $125 at JPMorgan
11/20/20 MKM Partners
Ross Stores price target raised to $124 from $105 at MKM Partners
11/20/20 Loop Capital
Ross Stores price target raised to $130 from $110 at Loop Capital
NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

01/13/21 Roth Capital
NV5 Global price target raised to $136 from $82 at Roth Capital
11/12/20 Roth Capital
NV5 Global price target raised to $82 from $77 at Roth Capital
08/24/20
Fly Intel: Top five analyst upgrades
08/24/20 Sidoti
Sidoti upgrades NV5 Global to Buy following pullback
REAL RealReal
$26.70 /

-1.48 (-5.25%)

02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 BTIG
RealReal price target raised to $32 from $27 at BTIG
02/23/21 Cowen
RealReal price target raised to $29 from $18 at Cowen
02/23/21 Raymond James
RealReal downgraded to Market Perform from Outperform at Raymond James
RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
05/21/20
Fly Intel: Top five analyst initiations
JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

02/16/21 JPMorgan
Nordstrom price target raised to $40 from $34 at JPMorgan
02/10/21 Gordon Haskett
Nordstrom upgraded to Buy from Hold at Gordon Haskett
01/21/21 Deutsche Bank
Nordstrom price target raised to $43 from $24 at Deutsche Bank
01/14/21 Credit Suisse
Nordstrom price target raised to $39 from $26 at Credit Suisse
URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

02/26/21 Deutsche Bank
Urban Outfitters named short-term investment idea at Deutsche Bank
02/10/21 RBC Capital
Urban Outfitters price target raised to $30 from $28 at RBC Capital
01/21/21 Deutsche Bank
Urban Outfitters price target raised to $32 from $31 at Deutsche Bank
01/14/21
Fly Intel: Top five analyst downgrades
ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

01/28/21 JonesTrading
Arena Pharmaceuticals initiated with a Buy at JonesTrading
11/19/20 SMBC Nikko
Arena Pharmaceuticals initiated with an Outperform at SMBC Nikko
11/10/20 RBC Capital
Arena Pharmaceuticals price target lowered to $76 from $80 at RBC Capital
11/02/20 JPMorgan
Arena Pharmaceuticals price target raised to $90 from $71 at JPMorgan
SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

01/19/21 Stifel
Stratasys initiated with a Buy at Stifel
01/15/21 JPMorgan
Stratasys downgraded to Underweight from Neutral at JPMorgan
10/09/20 Berenberg
Stratasys initiated with a Buy at Berenberg
09/24/20
Fly Intel: Top five analyst downgrades
ICAD iCAD
$18.88 /

-0.3 (-1.56%)

02/26/21 B. Riley
iCAD price target raised to $23 from $18 at B. Riley Securities
02/25/21 Oppenheimer
iCAD initiated with an Outperform at Oppenheimer
02/25/21 Craig-Hallum
iCAD price target raised to $22 from $15 at Craig-Hallum
02/25/21 Lake Street
iCAD price target raised to $21 from $17 at Lake Street
ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

02/26/21 HSBC
Airbnb price target raised to $224 from $220 at HSBC
02/26/21 Jefferies
Airbnb price target raised to $210 from $170 at Jefferies
02/26/21 DA Davidson
Airbnb price target raised to $210 from $172 at DA Davidson
02/26/21 Needham
Airbnb represents 'best way to play travel recovery', says Needham
VEC Vectrus
$55.59 /

+0.89 (+1.63%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

NVEE NV5 Global
$102.47 /

-2.59 (-2.47%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ICAD iCAD
$18.88 /

-0.3 (-1.56%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

  • 03
    Mar
  • 03
    Mar
  • 04
    Feb
  • 04
    Feb
  • 30
    Dec
  • 10
    Dec
  • 20
    Nov
  • 08
    Oct
  • 13
    Aug
  • 07
    Aug
  • 09
    Jul
  • 28
    May
  • 23
    Apr
ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

REAL RealReal
$26.70 /

-1.48 (-5.25%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

GO Grocery Outlet
$36.12 /

+0.19 (+0.53%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

URBN Urban Outfitters
$33.75 /

-0.4 (-1.17%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

RVMD Revolution Medicines
$44.36 /

-1.57 (-3.42%)

ROST Ross Stores
$117.75 /

-2.63 (-2.18%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

MRVI Maravai Lifesciences
$35.01 /

-1.43 (-3.92%)

LYFT Lyft
$57.06 /

-0.26 (-0.45%)

JWN Nordstrom
$37.45 /

-0.5 (-1.32%)

FUBO FuboTV
$41.96 /

+3.24 (+8.37%)

BGS B&G Foods
$30.44 /

-0.36 (-1.17%)

AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

ABNB Airbnb
$189.68 /

-6.16 (-3.15%)

Earnings
Quanterix reports Q4 loss from operations ($11.7M) vs. ($10.8M) last year » 16:07
03/02/21
03/02
16:07
03/02/21
16:07
QTRX

Quanterix

$76.45 /

-6.22 (-7.52%)

Reports Q4 revenue…

Reports Q4 revenue $26.1M, consensus $23.44M. "Responding to the pandemic crisis as well as advances in therapies to treat Alzheimer's has accelerated our leadership of precision health and the proteomics revolution," said CEO, Kevin Hrusovsky. "There is a strong demand for ultra-sensitive protein analytical tools to support disease studies, diagnostics and drug development as the COVID focus shifts from battling the acute virus to the long-hauler impact of the virus on organ and overall human health. We enter 2021 on strong footing as we scale Quanterix to support this unprecedented opportunity."

ShowHide Related Items >><<
QTRX Quanterix
$76.45 /

-6.22 (-7.52%)

QTRX Quanterix
$76.45 /

-6.22 (-7.52%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
  • 04
    Feb
  • 07
    Aug
QTRX Quanterix
$76.45 /

-6.22 (-7.52%)

QTRX Quanterix
$76.45 /

-6.22 (-7.52%)

Hot Stocks
Quanterix announces Simoa joint laboratory with WuXi AppTec » 14:12
02/12/21
02/12
14:12
02/12/21
14:12
QTRX

Quanterix

$87.68 /

+7.06 (+8.76%)

Quanterix announced it…

Quanterix announced it has entered into an agreement to open a joint Simoa laboratory with WuXi AppTec to improve access to Quanterix' "industry leading" biomarker testing and development offerings across China and the APAC market. The Simoa Joint Lab is the strategic partnership between the two companies and will be established at WuXi AppTec's Shanghai facility. "The facility will leverage Quanterix' ultra-sensitive Simoa HD-X Analyzers, consumables resources and technical expertise to advance essential pre-clinical and clinical research in the region," the company said. Kevin Hrusovsky, Chairman, CEO and President of Quanterix, added: "We're excited to provide access to Simoa technology to the APAC region. This partnership enables us to offer even deeper support to our customers in this region and is a testament to the passion and collaboration that is taking place across the world to eradicate disease and empower true precision health."

ShowHide Related Items >><<
QTRX Quanterix
$87.68 /

+7.06 (+8.76%)

QTRX Quanterix
$87.68 /

+7.06 (+8.76%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
  • 04
    Feb
  • 07
    Aug
QTRX Quanterix
$87.68 /

+7.06 (+8.76%)

QTRX Quanterix
$87.68 /

+7.06 (+8.76%)

Syndicate
Quanterix 3.6M share Spot Secondary priced at $70.00 » 07:19
02/04/21
02/04
07:19
02/04/21
07:19
QTRX

Quanterix

$72.49 /

-2.23 (-2.98%)

The deal size was…

The deal size was increased to $250M in stock from $200M in stock and the range was $68.00-$71.00. Goldman Sachs, SVB Leerink and Cowen acted as joint book running managers for the offering.

ShowHide Related Items >><<
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

  • 04
    Feb
  • 07
    Aug
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

Syndicate
Quanterix $200M Spot Secondary; price range $68.00-$71.00 » 17:04
02/03/21
02/03
17:04
02/03/21
17:04
QTRX

Quanterix

$72.49 /

-2.23 (-2.98%)

Goldman Sachs, SVB…

Goldman Sachs, SVB Leerink and Cowen are acting as joint book running managers for the offering.

ShowHide Related Items >><<
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

  • 07
    Aug
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

Syndicate
Quanterix announces offering of $200M of common stock offering » 16:27
02/03/21
02/03
16:27
02/03/21
16:27
QTRX

Quanterix

$72.49 /

-2.23 (-2.98%)

Quanterix Corporation…

Quanterix Corporation announced that it has commenced an underwritten public offering of $200M of its common stock. Goldman Sachs & Co., SVB Leerink, and Cowen and Company are acting as joint bookrunning managers for the offering. Canaccord Genuity is acting as lead manager for the offering.

ShowHide Related Items >><<
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

  • 07
    Aug
QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

QTRX Quanterix
$72.49 /

-2.23 (-2.98%)

Recommendations
Quanterix price target raised to $75 from $50 at SVB Leerink » 09:13
01/27/21
01/27
09:13
01/27/21
09:13
QTRX

Quanterix

$66.40 /

-9.76 (-12.82%)

SVB Leerink analyst…

SVB Leerink analyst Puneet Souda raised the firm's price target on Quanterix to $75 from $50 and keeps an Outperform rating on the shares. The analyst cites preliminary Q4 results and his revised outlook on 2021. Souda believes core to Quanterix's success is its neurology immunoassay franchise which is driving growth in clinical trials as Alzheimer's and other disorders are pursued and research into neurology grows further. He also recognizes that Quanterix's Simoa platform is levered to targeted proteomics.

ShowHide Related Items >><<
QTRX Quanterix
$66.40 /

-9.76 (-12.82%)

QTRX Quanterix
$66.40 /

-9.76 (-12.82%)

01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
10/06/20 Canaccord
Quanterix price target raised to $40 from $38 at Canaccord
QTRX Quanterix
$66.40 /

-9.76 (-12.82%)

  • 07
    Aug
QTRX Quanterix
$66.40 /

-9.76 (-12.82%)

QTRX Quanterix
$66.40 /

-9.76 (-12.82%)

Recommendations
Quanterix price target raised to $74 from $60 at Canaccord » 07:24
01/14/21
01/14
07:24
01/14/21
07:24
QTRX

Quanterix

$67.85 /

+8.25 (+13.84%)

Canaccord analyst Max…

Canaccord analyst Max Mascucci raised the firm's price target on Quanterix to $74 from $60 and keeps a Buy rating on the shares. The analyst noted its solid Q4 preannouncement revenue beat which demonstrated resilience and strength in its core research business. He expects its inclusion in the field of proteomics will mirror its success and advancement seen in the filed of genomics over the past 10 years.

ShowHide Related Items >><<
QTRX Quanterix
$67.85 /

+8.25 (+13.84%)

QTRX Quanterix
$67.85 /

+8.25 (+13.84%)

01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
10/06/20 Canaccord
Quanterix price target raised to $40 from $38 at Canaccord
08/05/20 JPMorgan
Quanterix price target raised to $40 from $30 at JPMorgan
QTRX Quanterix
$67.85 /

+8.25 (+13.84%)

  • 07
    Aug
QTRX Quanterix
$67.85 /

+8.25 (+13.84%)

QTRX Quanterix
$67.85 /

+8.25 (+13.84%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.